Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 283

1.

Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer.

Chelimo C, Wouldes TA, Cameron LD, Elwood JM.

J Infect. 2013 Mar;66(3):207-17. doi: 10.1016/j.jinf.2012.10.024. Epub 2012 Oct 26. Review.

PMID:
23103285
2.

High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys.

Rob F, Tachezy R, Pichlík T, Rob L, Kružicová Z, Hamšíková E, Šmahelová J, Hercogová J.

Dermatol Ther. 2017 Jan;30(1). doi: 10.1111/dth.12435. Epub 2016 Oct 9.

PMID:
27723194
3.

Spectrum of genital human papillomavirus infection in a female adolescent population.

Jamison JH, Kaplan DW, Hamman R, Eagar R, Beach R, Douglas JM Jr.

Sex Transm Dis. 1995 Jul-Aug;22(4):236-43.

PMID:
7482107
4.

Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.

Broomall EM, Reynolds SM, Jacobson RM.

Postgrad Med. 2010 Mar;122(2):121-9. doi: 10.3810/pgm.2010.03.2129. Review.

PMID:
20203463
5.

Human papillomavirus: clinical manifestations and prevention.

Juckett G, Hartman-Adams H.

Am Fam Physician. 2010 Nov 15;82(10):1209-13. Review.

6.

A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.

Goldstone SE, Vuocolo S.

Expert Rev Vaccines. 2012 Apr;11(4):395-406. doi: 10.1586/erv.12.20. Review.

PMID:
22551023
7.

Population impact of HPV vaccines: summary of early evidence.

Hariri S, Markowitz LE, Dunne EF, Unger ER.

J Adolesc Health. 2013 Dec;53(6):679-82. doi: 10.1016/j.jadohealth.2013.09.018. Review.

PMID:
24263069
8.

Epidemiology and natural history of genital human papillomavirus infection.

Weaver BA.

J Am Osteopath Assoc. 2006 Mar;106(3 Suppl 1):S2-8. Review.

PMID:
16729554
9.

Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection.

Brisson M, Van de Velde N, De Wals P, Boily MC.

CMAJ. 2007 Aug 28;177(5):464-8. Epub 2007 Aug 20.

10.

Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.

Poljak M, Seme K, Maver PJ, Kocjan BJ, Cuschieri KS, Rogovskaya SI, Arbyn M, Syrjänen S.

Vaccine. 2013 Dec 31;31 Suppl 7:H59-70. doi: 10.1016/j.vaccine.2013.03.029. Review.

PMID:
24332298
11.

Prevention strategies against the human papillomavirus: the effectiveness of vaccination.

Stanley M.

Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S19-23. Review.

PMID:
17938013
12.

Male circumcision and genital human papillomavirus: a systematic review and meta-analysis.

Albero G, Castellsagué X, Giuliano AR, Bosch FX.

Sex Transm Dis. 2012 Feb;39(2):104-13. doi: 10.1097/OLQ.0b013e3182387abd. Review.

PMID:
22249298
13.
14.

Awareness of human papillomavirus infection, genitoanal warts and cancer in a dermatological outpatient clinic setting.

Kuznetsov L, Reitmaier-Weber CM, Ruzicka T, Kuznetsov AV.

Acta Derm Venereol. 2013 Mar 27;93(2):218-22. doi: 10.2340/00015555-1431.

15.

Harnessing the power of prevention: human papillomavirus vaccines.

Mayeaux EJ Jr.

Curr Opin Obstet Gynecol. 2006 Feb;18 Suppl 1:s15-21. Review.

PMID:
16520680
16.

HPV vaccine update: new indications and controversies.

Mendoza N, Hernandez PO, Tyring SK.

Skin Therapy Lett. 2011 Sep;16(8):1-3. Review.

17.

Human papillomavirus and genital cancer.

Rapose A.

Indian J Dermatol Venereol Leprol. 2009 May-Jun;75(3):236-43; quiz 243-4. doi: 10.4103/0378-6323.48429. Review.

18.

An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention.

Forcier M, Musacchio N.

Dermatol Ther. 2010 Sep-Oct;23(5):458-76. doi: 10.1111/j.1529-8019.2010.01350.x. Review.

PMID:
20868401
19.

Start early to prevent genital HPV infection-and cervical cancer.

Heavey E.

Nursing. 2008 May;38(5):62-3. doi: 10.1097/01.NURSE.0000317694.60224.38. Review. No abstract available.

PMID:
18431214
20.

Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study.

Roura E, Iftner T, Vidart JA, Kjaer SK, Bosch FX, Muñoz N, Palacios S, Rodriguez MS, Morillo C, Serradell L, Torcel-Pagnon L, Cortes J, Castellsagué X; CLEOPATRE Spain Study Group.

BMC Infect Dis. 2012 Jun 26;12:145.

Supplemental Content

Support Center